Ahead of Print -Human Hantavirus Infections in the Netherlands - Volume 20, Number 12—December 2014 - Emerging Infectious Disease journal - CDC
Volume 20, Number 12—December 2014
Human Hantavirus Infections in the Netherlands
Hantaviruses (family Bunuyaviriade, genus Hantavirus) are primarily rodent-borne pathogens that are a suspected cause of hemorrhagic fever with renal syndrome (HFRS) in Eurasia (1). They are transmitted to humans mainly through aerosolized rodent excreta (1). Five hantaviruses circulate among rodents in Europe, but most human HFRS cases are caused by Puumala virus (PUUV) (1,2). The reservoir for PUUV is bank voles (Myodes glareolus), which are widespread in Europe (1,2). HFRS is a reportable disease in most countries in Europe, and cases are reported mostly from Finland, Sweden, and forest-rich regions of Belgium and Germany (1,3,4).
In the Netherlands, hantavirus infections have been reportable since December 2008, although voluntary laboratory surveillance has been in place since 1989. An earlier study in the Netherlands reported a seroprevalence of 0.7% among blood donors but higher prevalences in forest workers and animal trappers (5). Antibodies to PUUV, Tula virus (TULV), and Seoul virus (SEOV) have been found in rodent populations in the Netherlands, and TULV has been isolated from common voles (Microtus arvalis) (5,6). The purpose of this study was to report recent trends in human hantavirus infection and estimate seroprevalence in the Netherlands.
Dr Sane is a fellow in the European Programme for Intervention Epidemiology Training, European Centre for Disease Prevention and Control, at National Institute for Public Health and the Environment, Bilthoven, the Netherlands. His primary research interests include epidemiology of viral diseases, especially vaccine-preventable and vector-borne infections.
We thank Chantal Reusken for contributing to the study design and manuscript preparation.
J.S. was supported by the European Programme for Intervention Epidemiology Training, European Centre for Disease Prevention and Control.
- Vaheri A, Henttonen H, Voutilainen L, Mustonen J, Sironen T, Vapalahti O. Hantavirus infections in Europe and their impact on public health. Rev Med Virol. 2013;23:35–49.
- Olsson GE, Leirs H, Henttonen H. Hantaviruses and their hosts in Europe: reservoirs here and there, but not everywhere? Vector Borne Zoonotic Dis. 2010;10:549–61.
- Ahlm C, Linderholm M, Juto P, Stegmayr B, Settergren B. Prevalence of serum IgG antibodies to Puumala virus (haemorrhagic fever with renal syndrome) in northern Sweden. Epidemiol Infect. 1994;113:129–36.
- Zöller L, Faulde M, Meisel H, Ruh B, Kimmig P, Schelling U, Seroprevalence of hantavirus antibodies in Germany as determined by a new recombinant enzyme immunoassay. Eur J Clin Microbiol Infect Dis. 1995;14:305–13.
- Groen J, Gerding MN, Jordans JG, Clement JP, Nieuwenhuijs JH, Osterhaus AD. Hantavirus infections in The Netherlands: epidemiology and disease. Epidemiol Infect. 1995;114:373–83.
- Reusken C, de Vries A, Adema J, Vos W, van der Giessen J, Bekker D, First genetic detection of Tula hantavirus in wild rodents in the Netherlands. J Infect. 2008;57:500–3.
- van der Klis FR, Mollema L, Berbers GA, de Melker HE, Coutinho RA. Second national serum bank for population-based seroprevalence studies in the Netherlands. Neth J Med. 2009;67:301–8 .
- Jameson LJ, Logue CH, Atkinson B, Baker N, Galbraith SE, Carroll MW, The continued emergence of hantaviruses: isolation of a Seoul virus implicated in human disease, United Kingdom, October 2012. Euro Surveill. 2013;18:4–7 .
- Macé G, Feyeux C, Mollard N, Chantegret C, Audia S, Rebibou JM, Severe Seoul hantavirus infection in a pregnant woman, France, October 2012.Euro Surveill. 2013;18:20464 .
- Makary P, Kanerva M, Ollgren J, Virtanen MJ, Vapalahti O, Lyytikainen O. Disease burden of Puumala virus infections, 1995–2008. Epidemiol Infect.2010;138:1484–92.
- Faber MS, Ulrich RG, Frank C, Brockmann SO, Pfaff GM, Jacob J, Steep rise in notified hantavirus infections in Germany, April 2010. Euro Surveill.2010;15:19574 .
- Schwarz AC, Ranft U, Piechotowski I, Childs JE, Brockmann SO. Risk factors for human infection with Puumala virus, southwestern Germany. Emerg Infect Dis. 2009;15:1032–9.
- Voutilainen L, Savola S, Kallio ER, Laakkonen J, Vaheri A, Vapalahti O, Environmental change and disease dynamics: effects of intensive forest management on Puumala hantavirus infection in boreal bank vole populations. PLoS ONE. 2012;7:e39452.
- Hjertqvist M, Klein SL, Ahlm C, Klingstrom J. Mortality rate patterns for hemorrhagic fever with renal syndrome caused by Puumala virus. Emerg Infect Dis. 2010;16:1584–6.
- Krautkrämer E, Grouls S, Urban E, Schnitzler P, Zeier M. No gender-related differences in the severity of nephropathia epidemica, Germany. BMC Infect Dis. 2013;13:457 .
Suggested citation for this article: Sane J, Reimerink J, Harms M, Bakker J, Mughini-Gras L, Schimmer B, et al. Human hantavirus infections in the Netherlands. Emerg Infect Dis [Internet]. 2014 Dec [date cited]. http://dx.doi.org/10.3201/eid2012.131886